STEVENSON, Md., March 27, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Invuity, Inc. (Nasdaq:IVTY) (“Invuity” or the “Company”) common stock during the period between July 19, 2016 and November 3, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until April 28, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Invuity common stock during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the continued opportunities for growth in mature active accounts stagnated after the initial sale of a new product, revenues per active account were declining, and the Company’s sales force was not meeting stated revenue growth goals in mature active accounts.
According to the complaint, following a November 3, 2016 press release and conference call announcing a dramatic cut of the Company’s revenue expectations and 2017 guidance due to lower revenue per active account, the value of Invuity shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Invuity common stock purchased on or after July 19, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 



